Summit Trail Advisors, LLC Nektar Therapeutics Transaction History

Summit Trail Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$46.25 - $104.45 $967,873 - $2.19 Million	-20,927 Closed	0 $0
Q1 2018 May 22, 2018	SELL	$57.4 - $108.44 $70.2 Million - $133 Million	-1,223,345 Reduced 98.32%	20,927 $1.24 Million
Q1 2018 May 21, 2018	BUY	$57.4 - $108.44 $69.4 Million - $131 Million	1,208,266 Added 3355.74%	1,244,272 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $828,858 - $2.18 Million	36,006	36,006 $2.67 Million

15.6M

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $10.6B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit Trail Advisors, LLC with notifications on news.